2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Moser O, Zaharieva D, Adolfsson P, Battelino T, Bracken R, Buckingham B, Danne T, Davis E, Dovc K, Forlenza G, Gillard P, Hofer S, Hovorka R, Jacobs P, Mader J, Mathieu C, Nørgaard K, Oliver N, O’Neal D, Pemberton J, Rabasa-Lhoret R, Sherr J, Sourij H, Tauschmann M, Yardley J, Riddell M. The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD). Hormone Research In Paediatrics 2024, 1-28. PMID: 39657609, DOI: 10.1159/000542287.Peer-Reviewed Original ResearchEuropean Association for the Study of DiabetesPhysical activityInternational Society for Pediatric and Adolescent DiabetesType 1 diabetesRegular physical activityPosition statementDiabetes careStudy of DiabetesClinical practice pointsResponse to PAManaged PAsEuropean Association for the StudyHealth benefitsAge groupsExerciseAdolescent DiabetesAutomated insulin deliveryDiabetesInsulin deliveryGlucose target rangeTherapy optionsClinical trialsDeliveryGlucose levelsGlucose fluctuations
2009
From pumps to prevention: recent advances in the treatment of type 1 diabetes
Sherr J, Cengiz E, Tamborlane WV. From pumps to prevention: recent advances in the treatment of type 1 diabetes. Drug Discovery Today 2009, 14: 973-981. PMID: 19580883, DOI: 10.1016/j.drudis.2009.06.011.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAutoimmunityBiosensing TechniquesBlood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Drug Therapy, CombinationGlycated HemoglobinHumansHypoglycemic AgentsImmunologic FactorsInfusion PumpsInsulinInsulin-Secreting CellsPancreas, ArtificialPrimary PreventionTreatment OutcomeConceptsContinuous subcutaneous insulin infusionContinuous glucose monitoringType 1 diabetes mellitusBeta-cell destructionRapid-acting insulinSubcutaneous insulin infusionTreatment of T1DMType 1 diabetesBlood glucose fluctuationsImproved insulin deliveryAutoimmune processDiabetes mellitusPediatric patientsSecondary interventionsTreatment optionsInsulin infusionNew medicationsGlucose fluctuationsGlucose monitoringInsulin deliveryArtificial pancreasPreventionTreatmentInitial studyMellitus
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply